Skip to main content

Advertisement

SpringerLink
Log in

Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome

  • Reproductive Physiology and Disease
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this paper is to determine whether antimullerian hormone (AMH) levels were associated with BMI in patients with diagnosed infertility, and more specifically, in patients with polycystic ovarian syndrome (PCOS).

Methods

A retrospective cohort study reviewed all females who presented to the clinical investigators’ practice between November 2011 and March 2013. The following data was retrieved from the medical record: (1) AMH level, (2) age, (3) BMI, (4) ethnicity, and (5) if infertile, etiology of infertility.

Results

AMH levels were available for 489 women. Of these, 104 were diagnosed with PCOS. Overall, there was no association between BMI and AMH (r −0.04, p > 0.05). On the other hand, in the women with PCOS, there was a significant association between BMI and AMH (r −0.31, p < 0.01).

Conclusions

BMI was not associated with AMH levels in the general population of infertile women or in patients without PCOS. However, BMI appeared to be significantly and inversely correlated with AMH in women with PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Durlinger AL et al. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124(5):601–9.

    Article  CAS  PubMed  Google Scholar 

  2. Siefer DB et al. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95(2):747–50.

    Article  Google Scholar 

  3. Köninger A et al. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Hum Reprod. 2014;29(3):518–24.

    Article  PubMed  Google Scholar 

  4. Jonard S et al. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107–17.

    Article  PubMed  Google Scholar 

  5. van Rooij A et al. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17(12):3065–71.

    Article  PubMed  Google Scholar 

  6. Tal R et al. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119–30.e3.

    Article  CAS  PubMed  Google Scholar 

  7. Kissell KA. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29(8):1764–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Sheehan M. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2(1):13–27.

    Article  PubMed Central  PubMed  Google Scholar 

  9. March WA et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–51.

    Article  PubMed  Google Scholar 

  10. Homburg et al. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod. 2013;28(4):1077–83.

    Article  CAS  PubMed  Google Scholar 

  11. Caglar, et al. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. Arch Gynecol Obstet. 2013 Apr 4.

  12. Karkanaki A et al. The clinical significance of anti-Mullerian hormone evaluation in gynecological endocrinology. Horm. 2011;10(2):95–103.

    Article  Google Scholar 

  13. Piouka A et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296(2):E238–43.

    Article  CAS  PubMed  Google Scholar 

  14. Amer SA et al. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study. Reprod Biol Endocrinol. 2013;11:115.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Mahran A et al. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J Clin Endocrinol Metab. 2013;98(10):4170–5.

    Article  CAS  PubMed  Google Scholar 

  16. Panidis D. Serum LH levels are markedly increased and significantly correlated with Delta 4-androstendione levels in lean women with polycystic ovary syndrome.2005. Fertil Steril 84: 538–540.

  17. Katsikis I, et al. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. 2011. Eur J Obstet Gynecol Reprod Biol

  18. McDowell S et al. Clomiphene ovulation induction and higher-order multiple pregnancy. Aust N Z J Obstet Gynaecol. 2013;53(4):395–8.

    Article  PubMed  Google Scholar 

  19. Bailey AP et al. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. Am J Obstet Gynecol. 2014;211(2):163–e1-6.

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Financial support

None.

Author information

Authors and Affiliations

  1. Reproductive Endocrinology and Infertility, Baylor College of Medicine, 6651 Main St, Houston, TX, 77030, USA

    Maya Kriseman, Charity Mills, Ertug Kovanci, Haleh Sangi-Haghpeykar & William Gibbons

Authors
  1. Maya Kriseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charity Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ertug Kovanci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haleh Sangi-Haghpeykar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William Gibbons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maya Kriseman.

Additional information

Capsule

There is a significant inverse correlation between body mass index and antimullerian hormone level in women with polycystic ovary syndrome.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kriseman, M., Mills, C., Kovanci, E. et al. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome. J Assist Reprod Genet 32, 1313–1316 (2015). https://doi.org/10.1007/s10815-015-0540-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-015-0540-0

Keywords

Search

Navigation